Literature DB >> 10490332

Interlaboratory reproducibility of an enzyme-linked immunosorbent assay for quantitation of antibodies for Haemophilus influenzae type b polysaccharide.

D V Madore, S A Quataert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490332      PMCID: PMC103743          DOI: 10.1128/CDLI.6.3.446-446.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


× No keyword cloud information.
  3 in total

1.  A competitive enzyme-linked immunosorbent assay for measuring the levels of serum antibody to Haemophilus influenzae type b.

Authors:  M Mariani; E Luzzi; D Proietti; S Mancianti; D Casini; P Costantino; P van Gageldonk; G Berbers
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

2.  Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay.

Authors:  D V Madore; P Anderson; B D Baxter; G M Carlone; K M Edwards; R G Hamilton; P Holder; H Käyhty; D C Phipps; C C Peeters; R Schneerson; G R Siber; J I Ward; C E Frasch
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

3.  An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay.

Authors:  D C Phipps; J West; R Eby; M Koster; D V Madore; S A Quataert
Journal:  J Immunol Methods       Date:  1990-12-31       Impact factor: 2.303

  3 in total
  2 in total

1.  Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults.

Authors:  Uwe Schauer; Frank Stemberg; Christian H L Rieger; Wolfgang Büttner; Michael Borte; Simone Schubert; Helga Möllers; Frank Riedel; Udo Herz; Harald Renz; Wilhelm Herzog
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

2.  Reference ranges and cutoff levels of pneumococcal antibody global serum assays (IgG and IgG2) and specific antibodies in healthy children and adults.

Authors:  M A Rose; J Buess; Y Ventur; S Zielen; E Herrmann; J Schulze; R Schubert
Journal:  Med Microbiol Immunol       Date:  2013-03-26       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.